» Articles » PMID: 35652070

The Feasibility of Applying Artificial Intelligence to Gastrointestinal Endoscopy to Improve the Detection Rate of Early Gastric Cancer Screening

Overview
Specialty General Medicine
Date 2022 Jun 2
PMID 35652070
Authors
Affiliations
Soon will be listed here.
Abstract

Convolutional neural networks in the field of artificial intelligence show great potential in image recognition. It assisted endoscopy to improve the detection rate of early gastric cancer. The 5-year survival rate for advanced gastric cancer is less than 30%, while the 5-year survival rate for early gastric cancer is more than 90%. Therefore, earlier screening for gastric cancer can lead to a better prognosis. However, the detection rate of early gastric cancer in China has been extremely low due to many factors, such as the presence of gastric cancer without obvious symptoms, difficulty identifying lesions by the naked eye, and a lack of experience among endoscopists. The introduction of artificial intelligence can help mitigate these shortcomings and greatly improve the accuracy of screening. According to relevant reports, the sensitivity and accuracy of artificial intelligence trained on deep cirrocumulus neural networks are better than those of endoscopists, and evaluations also take less time, which can greatly reduce the burden on endoscopists. In addition, artificial intelligence can also perform real-time detection and feedback on the inspection process of the endoscopist to standardize the operation of the endoscopist. AI has also shown great potential in training novice endoscopists. With the maturity of AI technology, AI has the ability to improve the detection rate of early gastric cancer in China and reduce the death rate of gastric cancer related diseases in China.

Citing Articles

Functional Role of miR-499a-5p in the Development of Gastric Cancer.

Lu C, Guo C, Wu C, Liping Z, Liu X, Guo S Turk J Gastroenterol. 2025; 36(1):45-52.

PMID: 39782682 PMC: 11736815. DOI: 10.5152/tjg.2024.24429.


Predictive efficacy of combined tumor markers and gastrin for recurrence after endoscopic submucosal dissection in early gastric cancer patients.

Zhao B, Liu C, Ni S, Zhang Q Am J Transl Res. 2024; 16(5):2059-2069.

PMID: 38883344 PMC: 11170613. DOI: 10.62347/VOTO5604.


Prognostic Value and Potential Regulatory Mechanism of H19 in Stomach Adenocarcinoma.

Guo H, Guo X, Su Y, Liu M, Chen X, Zhu H J Oncol. 2022; 2022:7702626.

PMID: 36090894 PMC: 9452980. DOI: 10.1155/2022/7702626.

References
1.
Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M . Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014; 20(38):13842-62. PMC: 4194567. DOI: 10.3748/wjg.v20.i38.13842. View

2.
Sano T, Coit D, Kim H, Roviello F, Kassab P, Wittekind C . Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2016; 20(2):217-225. PMC: 4992472. DOI: 10.1007/s10120-016-0601-9. View

3.
Gao K, Wu J . National trend of gastric cancer mortality in China (2003-2015): a population-based study. Cancer Commun (Lond). 2019; 39(1):24. PMC: 6498569. DOI: 10.1186/s40880-019-0372-x. View

4.
Guo X, Zhao H, Shi Z, Wang Y, Jin M . [Application and Progress of Convolutional Neural Network-based Pathological Diagnosis of Gastric Cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021; 52(2):166-169. PMC: 10408929. DOI: 10.12182/20210360501. View

5.
Young E, Philpott H, Singh R . Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World J Gastroenterol. 2021; 27(31):5126-5151. PMC: 8384753. DOI: 10.3748/wjg.v27.i31.5126. View